Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

Heart

Volumn 84, Issue 6, 2000, Pages 653-658

  Nagaya, N ^a   Miyatake, K ^a   Kangawa, K ^a   Nishikimi, T ^a   Uematsu, M ^a   Satoh, T ^a   Oya, H ^a   Kyotani, S ^a   Sakamaki, F ^a   Ueno, K ^a   Nakanishi, N ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Haemodynamics; Pulmonary hypertension

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HORMONE; PLACEBO; RENIN; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INDEX; HEART RATE; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033659044     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.6.653     Document Type: Article

References (26)

1. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
2. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma
3. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma
4. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat
5. Increased plasma levels of adrenomedullin in patients with pulmonary hypertension
6. Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients < 20 years of age
7. Adrenomedullin dilates the pulmonary vascular bed in vivo
8. Pulmonary vasodilation to adrenomedullin: A novel peptide in humans
9. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats
10. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure
11. Hemodynamic, renal and hormonal effects of adrenomedullin infusion in patients with congestive heart failure
12. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline
13. Primary pulmonary hypertension: A national prospective study
14. Blood oxygen measurements in the assessment of intracardiac left to right shunts: A critical appraisal of methodology
15. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma
16. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue
17. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
18. Adrenomedullin stimulates Cyclic AMP formation in rat vascular smooth muscle cells
19. Mechanisms of adrenomedullin-induced increase of pulmonary blood flow in fetal sheep
20. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes
21. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide
22. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells
23. Clinical application of atrial natriuretic peptide in patients with congestive heart failure: Beneficial effects on left ventricular function
24. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
25. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
26. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension